Dr. Carl R. Schmidt

Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular. Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is rated as an Elite provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

"Kenneth K. Lee, MD, graduated Cum Laude from Harvard University with his BA in Chemistry, and continued on to the University of Chicago where he graduated with his MD in 1981. He also stayed at the University of Chicago for his surgical residency, becoming chief resident in 1987. His certifications include general surgery by the American Board of Surgery and also advanced trauma life support. His honors include being named one of the ""Best Doctors in America"" for 1996 - 2001 and receiving the Henry T. Bahnson Teaching Award in 2002.". Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Alessandro Paniccia, MD, FACS, is a surgical oncologist and specializes in pancreatic and hepatobiliary surgery. Dr. Paniccia's research interests include pancreatic cancer and hepato-pancreato-biliary (HPB) minimally invasive surgery. Dr. Paniccia is board-certified in general surgery. He received his medical degree from Sapienza University of Rome in Italy. Dr. Paniccia completed residencies in general surgery at Johns Hopkins University in Baltimore and the University of Colorado. He completed a research fellowship at the University of Colorado, followed by a fellowship in complex surgical oncology at UPMC. Dr. Paniccia is a member of the Roman Medical Association, American College of Surgeons, Society of Surgical Oncology, American Medical Association, and American Society of Clinical Oncology. Dr. Paniccia is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.